Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-12

Clinical Trial Update: Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid Hemorrhages [NA]

View source ↗

Summary

A clinical trial evaluating the use of human albumin to improve outcomes in patients with aneurysmal subarachnoid hemorrhage is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Albumin

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Aneurysmal Subarachnoid Hemorrhage | NA | Status: RECRUITING